Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review
- PMID: 29289377
- DOI: 10.1016/j.jsxm.2017.11.013
Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review
Abstract
Background: Different pharmacologic agents are used in the treatment of paraphilic disorders in sexual offenders or men with a risk of sexual offending, with luteinizing hormone-releasing hormone (LHRH) agonists being the agents introduced more recently to treatment regimens.
Aim: To summarize the relevant literature concerning LHRH agonist treatment of paraphilic disorders in sexual offenders and update the previously published systematic review by Briken et al (J Clin Psychiatry 2003;64:890-897).
Methods: The PubMed and Google Scholar databases were searched for literature published from January 2003 through October 2017 using the following key words: LHRH agonists, GnRH agonists, antiandrogens AND paraphilia, pedophilia, sex offenders.
Outcomes: Evaluation of the effectiveness and side effects of LHRH agonist treatment of paraphilic disorders in sexual offenders.
Results: After screening for duplicates and applying specific selection criteria, the search yielded 24 eligible studies reporting on a sample of 256 patients. There is increasing evidence that LHRH agonists are more effective than steroidal antiandrogens in lowering paraphilic sexual thoughts and behaviors. Current research also is based on methods that might be less susceptible to faking (eg, eye-tracking, brain imaging, and viewing-time measures). Side effects occurring most frequently are fatigue, hot flashes, depressive mood, weight gain, high blood pressure, diabetes, gynecomastia, loss of erectile function, and loss of bone mineral density.
Clinical implications: Although LHRH agonists seem to be the most effective drugs in the treatment of paraphilic fantasies and behaviors, they should be reserved for patients with a paraphilic disorder and the highest risk of sexual offending because of their extensive side effects.
Strengths and limitations: This systematic review considers all types of research on LHRH agonist treatment in patients with paraphilic disorders, thereby providing a complete overview of the current state of research. However, most studies are case reports or observational studies and randomized controlled clinical trials have not been conducted or published.
Conclusions: LHRH agonists are a useful treatment when combined with psychotherapy in patients with a paraphilic disorder and the highest risk of sexual offending. However, throughout treatment, close monitoring of side effects is needed and ethical concerns must always be kept in mind. Turner D, Briken P. Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review. J Sex Med 2018;15:77-93.
Keywords: Antiandrogens; Gonadotropin-Releasing Hormone Agonists; Luteinizing Hormone-Releasing Hormone Agonists; Paraphilia; Paraphilic Disorder; Pedophilia; Pedophilic Disorder; Sexual Offender; Treatment.
Copyright © 2017 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review.J Clin Psychiatry. 2003 Aug;64(8):890-7. doi: 10.4088/jcp.v64n0806. J Clin Psychiatry. 2003. PMID: 12927003 Review.
-
Drug treatment of paraphilic and nonparaphilic sexual disorders.Clin Ther. 2009 Jan;31(1):1-31. doi: 10.1016/j.clinthera.2009.01.009. Clin Ther. 2009. PMID: 19243704 Review.
-
Pharmacotherapy of sexual offenders.Ann Pharmacother. 1993 Mar;27(3):316-20. doi: 10.1177/106002809302700314. Ann Pharmacother. 1993. PMID: 8453171 Review.
-
[Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate].Nervenarzt. 2000 May;71(5):380-5. doi: 10.1007/s001150050572. Nervenarzt. 2000. PMID: 10846713 German.
-
Differential pharmacological treatment of paraphilias and sex offenders.Int J Offender Ther Comp Criminol. 2003 Aug;47(4):407-21. doi: 10.1177/0306624X03253847. Int J Offender Ther Comp Criminol. 2003. PMID: 12971182 Review.
Cited by
-
Pharmacological Interventions in Paraphilic Disorders: Systematic Review and Insights.J Clin Med. 2024 Mar 7;13(6):1524. doi: 10.3390/jcm13061524. J Clin Med. 2024. PMID: 38541750 Free PMC article. Review.
-
The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder.Dialogues Clin Neurosci. 2022 Dec;24(1):10-69. doi: 10.1080/19585969.2022.2134739. Dialogues Clin Neurosci. 2022. PMID: 37522807 Free PMC article.
-
Modelling sexual violence in male rats: the sexual aggression test (SxAT).Transl Psychiatry. 2022 May 18;12(1):207. doi: 10.1038/s41398-022-01973-3. Transl Psychiatry. 2022. PMID: 35585046 Free PMC article.
-
Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review.Drugs. 2022 Apr;82(6):663-681. doi: 10.1007/s40265-022-01696-1. Epub 2022 Apr 12. Drugs. 2022. PMID: 35414050 Free PMC article. Review.
-
Psychiatric disorders in female psychosexual disorders-a nationwide, cohort study in Taiwan : Psychiatric disorders and female psychosexual disorders.BMC Psychiatry. 2021 Jan 28;21(1):63. doi: 10.1186/s12888-021-03060-1. BMC Psychiatry. 2021. PMID: 33509146 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical